Abivax SA conducted an offering in the United States and is listed on Euronext Paris.
7 reports, 1 independent
Updated Jul 2
Gone quiet
- Reports
- 7
- Developments
- 1
- Repetition
- 86%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Abivax SA conducted an offering in the United States and is listed on Euronext Paris.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Euronext
pan-European bourse
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- GlobeNewswireAbivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M) Abivax Announces Full Exercise of Underwriters’ Option to
- GlobeNewswireAbivax announces temporary trading halt of its ordinary shares on Euronext Paris Abivax announces temporary trading halt of its ordinary shares on Euronext Paris PARIS, France, July 24, 2025 – 07:30
- GlobeNewswireAbivax announces trading resumption of its ordinary shares on Euronext Paris Abivax announces trading resumption of its ordinary shares on Euronext Paris PARIS, France, July 24, 2025 – 02:30 p.m. (CE
- GlobeNewswireAbivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares PARIS, France, July 24,
- GlobeNewswireAbivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis